Type 1 diabetes alters ischemia-induced gene expression

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Molecular Biology

Background:

• Peripheral Artery Disease (PAD) is a chronic condition caused by blocked arteries outside the heart.
• Type 1 Diabetes (T1D) significantly increases PAD risk and leads to poorer outcomes.
• The specific molecular mechanisms linking T1D and PAD severity are not fully understood.

Purpose of the Study:

• To investigate the molecular differences in ischemic muscle tissue between T1D and non-diabetic mice.
• To identify specific genes and biological pathways affected by comorbid T1D in PAD.

Main Methods:

• Experimental hind limb ischemia was induced in T1D and non-diabetic mouse models.
• Genome-wide mRNA transcriptome and pathway analysis were performed on gastrocnemius muscle tissue.
• Statistical analysis identified significant gene expression differences (p < 0.005).

Main Results:

• 443 differentially expressed genes were identified between ischemic diabetic and non-diabetic muscle tissues.
• Key affected pathways include cell cycle, DNA replication, metabolic pathways, focal adhesion, actin cytoskeleton regulation, and nucleotide excision repair.
• These findings highlight molecular alterations in T1D-associated PAD.

Conclusions:

• The study provides a comprehensive list of genes and pathways altered in PAD with T1D.
• These data can inform future research into the mechanisms driving poor PAD outcomes in diabetes.
• Identifying these molecular targets may lead to novel therapeutic strategies for patients with both conditions.